The Cooperative Family Registry for Breast Cancer Studies (CFRBCS) was initiated by the National Cancer Institute (NCI) to provide a resource for multidisciplinary studies of breast and ovarian cancer. The 6 participating sites have accumulated a large computerized data base with genetic and environmental risk information from an ethnically diverse set of families with a history of breast and/or ovarian cancer. Plasma and DNA are available for all participants, and tumor specimens have been obtained from those with a diagnosis of breast/ovarian cancer. The combined resources available in the CFRBCS have already begun to create unprecedented research opportunities for the genetic community. The identification of the family as the unit of study in cancer research provides an exceptional opportunity to explore the multifactorial contribution of genetic, environmental and lifestyle factors associated with the risk of cancer. The recognition of a familial risk for cancer, however, has vast personal, medical, social and ethical implications for those involved. The fast pace of discovery in the area of cancer genetics must be accompanied by a shift in paradigms to identify the family, rather than the individual, as the unit of cancer risk, to examine the impact of risk information on family dynamics, and to develop novel mechanisms of risk communication within families to maximize the preventive potential of the new science. The CFRBCS has a unique opportunity to engage study families in a partnership to explore sociocultural differences in the behavioral and social issues faced by individuals and their families as they formulate relevant perceptions of their risk for cancer and as they attempt to communicate risk information within the family. The proposed study will first explore the determinants of individual and familial participation in a breast cancer registry with both a retrospective approach to characterize the families recruited to date and a prospective approach applied to the proposed effort to extend recruitment of families. It will then examine the dynamics of familial communication patterns as they relate to cancer risk information, and the impact of registry participation on health-related behaviors among family members.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01CA069631-08
Application #
6563860
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
8
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Dite, Gillian S; MacInnis, Robert J; Bickerstaffe, Adrian et al. (2017) Testing for Gene-Environment Interactions Using a Prospective Family Cohort Design: Body Mass Index in Early and Later Adulthood and Risk of Breast Cancer. Am J Epidemiol 185:487-500
Dite, Gillian S; MacInnis, Robert J; Bickerstaffe, Adrian et al. (2016) Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 25:359-65
Rebbeck, Timothy R (see original citation for additional authors) (2015) Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. JAMA 313:1347-61
Antoniou, Antonis C; Casadei, Silvia; Heikkinen, Tuomas et al. (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371:497-506
Ferris, J S; Daly, M B; Buys, S S et al. (2014) Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry. Br J Cancer 110:1074-80
Dite, Gillian S; Mahmoodi, Maryam; Bickerstaffe, Adrian et al. (2013) Using SNP genotypes to improve the discrimination of a simple breast cancer risk prediction model. Breast Cancer Res Treat 139:887-96
Gracia-Aznarez, Francisco Javier; Fernandez, Victoria; Pita, Guillermo et al. (2013) Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles. PLoS One 8:e55681
Gaudet, Mia M; Kuchenbaecker, Karoline B; Vijai, Joseph et al. (2013) Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet 9:e1003173
Mocci, Evelina; Milne, Roger L; Méndez-Villamil, Elena Yuste et al. (2013) Risk of pancreatic cancer in breast cancer families from the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 22:803-11
Dowty, James G; Win, Aung K; Buchanan, Daniel D et al. (2013) Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 34:490-7

Showing the most recent 10 out of 73 publications